{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:36:07Z","timestamp":1791729367002,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,12,20]],"date-time":"2007-12-20T00:00:00Z","timestamp":1198108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,12,20]],"date-time":"2007-12-20T00:00:00Z","timestamp":1198108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1038\/sj.leu.2405072","type":"journal-article","created":{"date-parts":[[2007,12,20]],"date-time":"2007-12-20T11:40:39Z","timestamp":1198150839000},"page":"504-510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome"],"prefix":"10.1038","volume":"22","author":[{"given":"U","family":"Nor\u00e9n-Nystr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Botling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"L\u00f6nnerholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Porwit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Heyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Forestier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,12,20]]},"reference":[{"key":"BF2405072_CR1","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1038\/sj.leu.2401961","volume":"14","author":"G Gustafsson","year":"2000","unstructured":"Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G et al. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia 2000; 14: 2267\u20132275.","journal-title":"Leukemia"},{"key":"BF2405072_CR2","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/sj.leu.2404688","volume":"21","author":"A Andersson","year":"2007","unstructured":"Andersson A, Ritz C, Lindgren D, Eden P, Lassen C, Heldrup J et al. Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status. Leukemia 2007; 21: 1198\u20131203.","journal-title":"Leukemia"},{"key":"BF2405072_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/sj.leu.2402736","volume":"17","author":"E Bjorklund","year":"2003","unstructured":"Bjorklund E, Mazur J, Soderhall S, Porwit-MacDonald A . Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia. Leukemia 2003; 17: 138\u2013148.","journal-title":"Leukemia"},{"key":"BF2405072_CR4","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/blood.V96.8.2691","volume":"96","author":"E Coustan-Smith","year":"2000","unstructured":"Coustan-Smith E, Sancho J, Hancock ML, Boyett JM, Behm FG, Raimondi SC et al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood 2000; 96: 2691\u20132696.","journal-title":"Blood"},{"key":"BF2405072_CR5","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1182\/blood.V99.4.1253","volume":"99","author":"C Nyvold","year":"2002","unstructured":"Nyvold C, Madsen HO, Ryder LP, Seyfarth J, Svejgaard A, Clausen N et al. Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome. Blood 2002; 99: 1253\u20131258.","journal-title":"Blood"},{"key":"BF2405072_CR6","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","volume":"352","author":"JJ van Dongen","year":"1998","unstructured":"van Dongen JJ, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 1998; 352: 1731\u20131738.","journal-title":"Lancet"},{"key":"BF2405072_CR7","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/sj.leu.2402872","volume":"17","author":"H Gadner","year":"2003","unstructured":"Gadner H, Haas OA, Masera G, Pui CH, Schrappe M . \u2018Ponte di Legno\u2019 Working Group\u2014report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 29 April \u2013 1 May 2002. Leukemia 2003; 17: 798\u2013803..","journal-title":"Leukemia"},{"key":"BF2405072_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1470-2045(01)00516-2","volume":"2","author":"CH Pui","year":"2001","unstructured":"Pui CH, Campana D, Evans WE . Childhood acute lymphoblastic leukaemia\u2014current status and future perspectives. Lancet Oncol 2001; 2: 597\u2013607.","journal-title":"Lancet Oncol"},{"key":"BF2405072_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/35094059","volume":"1","author":"MJ Bissell","year":"2001","unstructured":"Bissell MJ, Radisky D . Putting tumours in context. Nat Rev Cancer 2001; 1: 46\u201354.","journal-title":"Nat Rev Cancer"},{"key":"BF2405072_CR10","first-page":"1128","volume":"90","author":"J Thiele","year":"2005","unstructured":"Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der Walt J, Orazi A . European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 2005; 90: 1128\u20131132.","journal-title":"Haematologica"},{"key":"BF2405072_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1053\/hupa.2003.58","volume":"34","author":"G Buesche","year":"2003","unstructured":"Buesche G, Georgii A, Duensing A, Schmeil A, Schlue J, Kreipe HH . Evaluating the volume ratio of bone marrow affected by fibrosis: a parameter crucial for the prognostic significance of marrow fibrosis in chronic myeloid leukemia. Hum Pathol 2003; 34: 391\u2013401.","journal-title":"Hum Pathol"},{"key":"BF2405072_CR12","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1200\/JCO.2001.19.12.2994","volume":"19","author":"HM Kvasnicka","year":"2001","unstructured":"Kvasnicka HM, Thiele J, Schmitt-Graeff A, Diehl V, Zankovich R, Niederle N et al. Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial. J Clin Oncol 2001; 19: 2994\u20133009.","journal-title":"J Clin Oncol"},{"key":"BF2405072_CR13","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1136\/jcp.42.12.1253","volume":"42","author":"JP Wallis","year":"1989","unstructured":"Wallis JP, Reid MM . Bone marrow fibrosis in childhood acute lymphoblastic leukaemia. J Clin Pathol 1989; 42: 1253\u20131254.","journal-title":"J Clin Pathol"},{"key":"BF2405072_CR14","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0145-2126(02)00034-6","volume":"26","author":"X Thomas","year":"2002","unstructured":"Thomas X, Le QH, Danaila C, Lheritier V, Ffrench M . Bone marrow biopsy in adult acute lymphoblastic leukemia: morphological characteristics and contribution to the study of prognostic factors. Leuk Res 2002; 26: 909\u2013918.","journal-title":"Leuk Res"},{"key":"BF2405072_CR15","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0301-472X(03)00159-0","volume":"31","author":"A Narendran","year":"2003","unstructured":"Narendran A, Ganjavi H, Morson N, Connor A, Barlow JW, Keystone E et al. Mutant p53 in bone marrow stromal cells increases VEGF expression and supports leukemia cell growth. Exp Hematol 2003; 31: 693\u2013701.","journal-title":"Exp Hematol"},{"key":"BF2405072_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.leukres.2004.04.018","volume":"29","author":"S Wu","year":"2005","unstructured":"Wu S, Korte A, Kebelmann-Betzing C, Gessner R, Henze G, Seeger K . Interaction of bone marrow stromal cells with lymphoblasts and effects of prednisolone on cytokine expression. Leuk Res 2005; 29: 63\u201372.","journal-title":"Leuk Res"},{"key":"BF2405072_CR17","first-page":"317","volume":"9","author":"D Campana","year":"1996","unstructured":"Campana D, Coustan-Smith E, Manabe A, Kumagai M, Murti KG, Silvennoinen O et al. Human B-cell progenitors and bone marrow microenvironment. Hum Cell 1996; 9: 317\u2013322.","journal-title":"Hum Cell"},{"key":"BF2405072_CR18","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/sj.leu.2403953","volume":"19","author":"U Nor\u00e9n-Nystr\u00f6m","year":"2005","unstructured":"Nor\u00e9n-Nystr\u00f6m U, Roos G, Bergh A, Forestier E . Prognostic impact of vascular density and fibrosis in the bone marrow of children with high-risk acute lymphoblastic leukemia. Leukemia 2005; 19: 1998\u20132001.","journal-title":"Leukemia"},{"key":"BF2405072_CR19","volume-title":"Theory and Practice of Histological Techniques","author":"JD Bancroft","year":"2001","unstructured":"Bancroft JD, Gamble M . Theory and Practice of Histological Techniques. Churchill Livingstone: Edinburgh, 2001."},{"key":"BF2405072_CR20","first-page":"107","volume-title":"Manual of Histological Staining Methods","author":"FA Putt","year":"1972","unstructured":"Putt FA . Laidlaw's lithium silver carbonate method to demonstrate reticulin. In: Putt FA (ed). Manual of Histological Staining Methods. John Wiley & Sons: New York, 1972, pp 107\u2013109."},{"key":"BF2405072_CR21","first-page":"1","volume-title":"Stereological Methods Vol 1: Practical Methods for Biological Morphometry","author":"E Weibel","year":"1979","unstructured":"Weibel E . Stereological methods. In: Stereological Methods Vol 1: Practical Methods for Biological Morphometry. Academic Press: New York, 1979, pp 1\u2013415."},{"key":"BF2405072_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1365-2141.2000.02153.x","volume":"110","author":"E Forestier","year":"2000","unstructured":"Forestier E, Johansson B, Gustafsson G, Borgstrom G, Kerndrup G, Johannsson J et al. Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukaemia Cytogenetic Study Group. Br J Haematol 2000; 110: 147\u2013153.","journal-title":"Br J Haematol"},{"key":"BF2405072_CR23","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood.V96.9.3161","volume":"96","author":"KA Aziz","year":"2000","unstructured":"Aziz KA, Till KJ, Zuzel M, Cawley JC . Involvement of CD44-hyaluronan interaction in malignant cell homing and fibronectin synthesis in hairy cell leukemia. Blood 2000; 96: 3161\u20133167.","journal-title":"Blood"},{"key":"BF2405072_CR24","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1182\/blood.V94.6.2080","volume":"94","author":"AE Kossakowska","year":"1999","unstructured":"Kossakowska AE, Edwards DR, Prusinkiewicz C, Zhang MC, Guo D, Urbanski SJ et al. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. Blood 1999; 94: 2080\u20132089.","journal-title":"Blood"},{"key":"BF2405072_CR25","first-page":"223","volume":"16","author":"R Pegahi","year":"2005","unstructured":"Pegahi R, Poyer F, Legrand E, Cazin L, Vannier JP, Lamacz M . Spontaneous and cytokine-evoked production of matrix metalloproteinases by bone marrow and peripheral blood pre-B cells in childhood acute lymphoblastic leukaemia. Eur Cytokine Netw 2005; 16: 223\u2013232.","journal-title":"Eur Cytokine Netw"},{"key":"BF2405072_CR26","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1182\/blood.V97.2.346","volume":"97","author":"F Sanz-Rodriguez","year":"2001","unstructured":"Sanz-Rodriguez F, Hidalgo A, Teixido J . Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1\/fibronectin and VCAM-1. Blood 2001; 97: 346\u2013351.","journal-title":"Blood"},{"key":"BF2405072_CR27","first-page":"815","volume":"150","author":"AR Perez-Atayde","year":"1997","unstructured":"Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J . Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997; 150: 815\u2013821.","journal-title":"Am J Pathol"},{"key":"BF2405072_CR28","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1046\/j.1365-2141.2002.03761.x","volume":"118","author":"MA Pule","year":"2002","unstructured":"Pule MA, Gullmann C, Dennis D, McMahon C, Jeffers M, Smith OP . Increased angiogenesis in bone marrow of children with acute lymphoblastic leukaemia has no prognostic significance. Br J Haematol 2002; 118: 991\u2013998.","journal-title":"Br J Haematol"},{"key":"BF2405072_CR29","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1038\/sj.leu.2404917","volume":"21","author":"G Buesche","year":"2007","unstructured":"Buesche G, Ganser A, Schlegelberger B, von Neuhoff N, Gadzicki D, Hecker H et al. Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia. Leukemia 2007; 21: 2420\u20132427.","journal-title":"Leukemia"},{"key":"BF2405072_CR30","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1200\/JCO.1999.17.3.818","volume":"17","author":"CH Pui","year":"1999","unstructured":"Pui CH, Boyett JM, Relling MV, Harrison PL, Rivera GK, Behm FG et al. Sex differences in prognosis for children with acute lymphoblastic leukemia. J Clin Oncol 1999; 17: 818\u2013824.","journal-title":"J Clin Oncol"},{"key":"BF2405072_CR31","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1200\/JCO.1995.13.2.345","volume":"13","author":"K Schmiegelow","year":"1995","unstructured":"Schmiegelow K, Schroder H, Gustafsson G, Kristinsson J, Glomstein A, Salmi T et al. Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology. J Clin Oncol 1995; 13: 345\u2013351.","journal-title":"J Clin Oncol"},{"key":"BF2405072_CR32","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1200\/JCO.1998.16.8.2854","volume":"16","author":"JJ Shuster","year":"1998","unstructured":"Shuster JJ, Wacker P, Pullen J, Humbert J, Land VJ, Mahoney Jr DH et al. Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol 1998; 16: 2854\u20132863.","journal-title":"J Clin Oncol"},{"key":"BF2405072_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/mpo.10052","volume":"38","author":"BM Frost","year":"2002","unstructured":"Frost BM, Eksborg S, Bjork O, Abrahamsson J, Behrendtz M, Castor A et al. Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: multi-institutional collaborative study. Med Pediatr Oncol 2002; 38: 329\u2013337.","journal-title":"Med Pediatr Oncol"},{"key":"BF2405072_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/00043426-199703000-00002","volume":"19","author":"K Schmiegelow","year":"1997","unstructured":"Schmiegelow K, Glomstein A, Kristinsson J, Salmi T, Schroder H, Bjork O . Impact of morning versus evening schedule for oral methotrexate and 6-mercaptopurine on relapse risk for children with acute lymphoblastic leukemia. Nordic Society for Pediatric Hematology and Oncology (NOPHO). J Pediatr Hematol Oncol 1997; 19: 102\u2013109.","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2405072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2405072","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2405072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:01:49Z","timestamp":1648782109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2405072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,20]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["BF2405072"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2405072","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,20]]},"assertion":[{"value":"28 September 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}